NCT00289042View on ClinicalTrials.gov

Assessment of Cardioversion Using Transesophageal Echocardiography II (ACUTE II)

PHASE4CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

December 31, 1999

Study Completion Date

November 30, 2004

Conditions
Atrial Fibrillation
Interventions
DRUG

Enoxaparin

Trial Locations (1)

44195

Cleveland Clinic, Cleveland

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

The Cleveland Clinic

OTHER